Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Journal of Medicinal Chemistry
|
June 16, 2026
Discovery and Pharmacological Characterization of a Dual-Acting 2-Amino-3-Cyanopyridine Inhibitor Targeting Microtubule Polymerization and GAK
Seulki Park, Eun Yeong Kim, Ji-Eun Lee, et al.
Biochemical and Biophysical Research Communications
|
July 15, 2015
Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins
Chung Hyo Kang, Jeong In Yun, Kwangho Lee, et al.
Bioorganic & Medicinal Chemistry
|
December 30, 2015
Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors
Raghavendra Achary, Jeong In Yun, Chi Min Park, et al.
European Journal of Medicinal Chemistry
|
December 5, 2016
Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R
Gangadhar Rao Mathi, Chung Hyo Kang, Heung Kyoung Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 3, 2014
Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors
Junwon Kim, Jeongjin Kwon, Doohyun Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 20, 2012
Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor
Jong Yeon Hwang, Marc Peter Windisch, Suyeon Jo, et al.
European Heart Journal
|
February 22, 2022
Cereblon contributes to cardiac dysfunction by degrading Cav1.2α
Nammi Park, Jubert Marquez, Trong Kha Pham, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 5, 2012
Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors
Junwon Kim, Jeongjin Kwon, Doohyun Lee, et al.
Oncogene
|
March 10, 2026
Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD)
Koushik Guchhait, Hyeon-Seung Yoon, Hyun-Su An, et al.
European Journal of Medicinal Chemistry
|
January 27, 2019
A novel cereblon modulator for targeted protein degradation
Sung Ah Kim, Ara Go, Seung-Hyun Jo, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Journal of Medicinal Chemistry
|
June 16, 2026
Discovery and Pharmacological Characterization of a Dual-Acting 2-Amino-3-Cyanopyridine Inhibitor Targeting Microtubule Polymerization and GAK
Seulki Park, Eun Yeong Kim, Ji-Eun Lee, et al.
Biochemical and Biophysical Research Communications
|
July 15, 2015
Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins
Chung Hyo Kang, Jeong In Yun, Kwangho Lee, et al.
Bioorganic & Medicinal Chemistry
|
December 30, 2015
Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors
Raghavendra Achary, Jeong In Yun, Chi Min Park, et al.
European Journal of Medicinal Chemistry
|
December 5, 2016
Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R
Gangadhar Rao Mathi, Chung Hyo Kang, Heung Kyoung Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 3, 2014
Serendipitous discovery of 2-((phenylsulfonyl)methyl)-thieno[3,2-d]pyrimidine derivatives as novel HIV-1 replication inhibitors
Junwon Kim, Jeongjin Kwon, Doohyun Lee, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 20, 2012
Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor
Jong Yeon Hwang, Marc Peter Windisch, Suyeon Jo, et al.
European Heart Journal
|
February 22, 2022
Cereblon contributes to cardiac dysfunction by degrading Cav1.2α
Nammi Park, Jubert Marquez, Trong Kha Pham, et al.
Bioorganic & Medicinal Chemistry Letters
|
December 5, 2012
Synthesis and biological evaluation of triazolothienopyrimidine derivatives as novel HIV-1 replication inhibitors
Junwon Kim, Jeongjin Kwon, Doohyun Lee, et al.
Oncogene
|
March 10, 2026
Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD)
Koushik Guchhait, Hyeon-Seung Yoon, Hyun-Su An, et al.
European Journal of Medicinal Chemistry
|
January 27, 2019
A novel cereblon modulator for targeted protein degradation
Sung Ah Kim, Ara Go, Seung-Hyun Jo, et al.
Page
of 6